Xiaokui Mo

9.5k total citations · 1 hit paper
217 papers, 6.1k citations indexed

About

Xiaokui Mo is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Xiaokui Mo has authored 217 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 55 papers in Immunology and 41 papers in Oncology. Recurrent topics in Xiaokui Mo's work include Chronic Lymphocytic Leukemia Research (35 papers), Immune Cell Function and Interaction (22 papers) and Monoclonal and Polyclonal Antibodies Research (16 papers). Xiaokui Mo is often cited by papers focused on Chronic Lymphocytic Leukemia Research (35 papers), Immune Cell Function and Interaction (22 papers) and Monoclonal and Polyclonal Antibodies Research (16 papers). Xiaokui Mo collaborates with scholars based in United States, China and Germany. Xiaokui Mo's co-authors include Natarajan Muthusamy, John C. Byrd, Kathi J. Kemper, Rami Khayat, Phillip G. Popovich, Arnab Chakravarti, Arunark Kolipaka, Jodie C.E. Hall, Thomas D. Schmittgen and Jinmai Jiang and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Xiaokui Mo

207 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells

2017 447 citations Mohamed Badawi, Xiaokui Mo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaokui Mo United States	41	2.7k	1.2k	1.1k	1.1k	736	217	6.1k
Daniel C. Anthony United Kingdom	60	4.1k 1.5×	919 0.8×	1.8k 1.6×	803 0.7×	1.3k 1.8×	263	11.3k
Daohong Zhou United States	53	4.8k 1.8×	1.2k 1.0×	1.4k 1.3×	1.5k 1.3×	327 0.4×	175	9.5k
Daniel Sinnett Canada	51	3.7k 1.4×	1.0k 0.8×	605 0.5×	1.2k 1.1×	528 0.7×	296	8.8k
Markus Glatzel Germany	53	5.5k 2.0×	891 0.8×	825 0.7×	932 0.8×	217 0.3×	294	9.7k
Akiva Mintz United States	39	2.1k 0.8×	747 0.6×	606 0.5×	1.1k 1.0×	181 0.2×	175	5.9k
Fan Zhang China	49	5.5k 2.0×	2.7k 2.3×	1.0k 0.9×	981 0.9×	390 0.5×	476	10.1k
Jorge D. Erusalimsky United Kingdom	39	3.4k 1.2×	610 0.5×	1.2k 1.1×	615 0.5×	339 0.5×	87	8.0k
Wen Fu Taiwan	50	3.7k 1.4×	1.1k 0.9×	875 0.8×	822 0.7×	222 0.3×	257	8.0k
Jun Wang China	40	2.2k 0.8×	1.1k 0.9×	554 0.5×	1.2k 1.1×	808 1.1×	269	6.3k
Maria B. Grant United States	55	5.4k 2.0×	1.0k 0.9×	920 0.8×	771 0.7×	273 0.4×	235	11.2k

Countries citing papers authored by Xiaokui Mo

Since Specialization

Citations

This map shows the geographic impact of Xiaokui Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaokui Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaokui Mo more than expected).

Fields of papers citing papers by Xiaokui Mo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaokui Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaokui Mo. The network helps show where Xiaokui Mo may publish in the future.

Co-authorship network of co-authors of Xiaokui Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaokui Mo. A scholar is included among the top collaborators of Xiaokui Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaokui Mo. Xiaokui Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Shiqi, Ming Hu, Fouad Choueiry, et al.. (2024). Distinct plasma molecular profiles between early-onset and late-onset colorectal cancer patients revealed by metabolic and lipidomic analyses. Journal of Pharmaceutical and Biomedical Analysis. 241. 115978–115978. 2 indexed citations

Peters, Sara, Rita Mitra, Xiaokui Mo, et al.. (2021). Dopamine Prevents Ultraviolet B–induced Development and Progression of Premalignant Cutaneous Lesions through its D2 Receptors. Cancer Prevention Research. 14(7). 687–696. 2 indexed citations

Thangavadivel, Shanmugapriya, Qiuhong Zhao, Narendranath Epperla, et al.. (2020). Early Intervention with Lenalidomide in Patients with High-risk Chronic Lymphocytic Leukemia. Clinical Cancer Research. 26(23). 6187–6195. 3 indexed citations

Mo, Xiaokui, C. Barney, J.C. Grecula, et al.. (2017). Tumor Volume Dynamics on kV-CBCT During Definitive Radiation Therapy for Locally Advanced NSCLC: Implications for Prognosis and Adaptive Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 99(2). E499–E500. 1 indexed citations

Geng, Feng, Xiang Cheng, Xiaoning Wu, et al.. (2016). Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis. Clinical Cancer Research. 22(21). 5337–5348. 244 indexed citations

Bertino, Erin M., Elizabeth L. McMichael, Xiaokui Mo, et al.. (2016). A Phase I Trial to Evaluate Antibody-Dependent Cellular Cytotoxicity of Cetuximab and Lenalidomide in Advanced Colorectal and Head and Neck Cancer. Molecular Cancer Therapeutics. 15(9). 2244–2250. 22 indexed citations

Stiff, Andrew, Enrico Caserta, Douglas W. Sborov, et al.. (2016). Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple Myeloma. Molecular Cancer Therapeutics. 15(5). 830–841. 31 indexed citations

Bid, Hemant K., Doris A. Phelps, Denis C. Guttridge, et al.. (2016). The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma. Molecular Cancer Therapeutics. 15(5). 1018–1028. 66 indexed citations

Gupta, Nikhil, Jeffrey A. Jones, Xiaokui Mo, et al.. (2016). Lenalidomide Induces Interleukin-21 Production by T Cells and Enhances IL21-Mediated Cytotoxicity in Chronic Lymphocytic Leukemia B Cells. Cancer Immunology Research. 4(8). 698–707. 13 indexed citations

10.

McMichael, Elizabeth L., Alena Cristina Jaime‐Ramirez, Kristan Guenterberg, et al.. (2016). IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells. Clinical Cancer Research. 23(2). 489–502. 55 indexed citations

11.

Hawley, Jeffrey, et al.. (2016). Quantification of breast stiffness using MR elastography at 3 Tesla with a soft sternal driver: A reproducibility study. Journal of Magnetic Resonance Imaging. 45(5). 1379–1384. 38 indexed citations

12.

Bell, Erica H., Arup R. Chakraborty, Xiaokui Mo, et al.. (2015). SMARCA4 /BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non–Small Cell Lung Cancer. Clinical Cancer Research. 22(10). 2396–2404. 115 indexed citations

13.

Kemper, Kathi J., Xiaokui Mo, & Rami Khayat. (2015). Are Mindfulness and Self-Compassion Associated with Sleep and Resilience in Health Professionals?. The Journal of Alternative and Complementary Medicine. 21(8). 496–503. 182 indexed citations

14.

Chou, Chih-Chien, Kuen‐Haur Lee, I‐Lu Lai, et al.. (2014). AMPK Reverses the Mesenchymal Phenotype of Cancer Cells by Targeting the Akt–MDM2–Foxo3a Signaling Axis. Cancer Research. 74(17). 4783–4795. 147 indexed citations

15.

Price, Richard L., Jieun Song, Katherine Bingmer, et al.. (2013). Cytomegalovirus Contributes to Glioblastoma in the Context of Tumor Suppressor Mutations. Cancer Research. 73(11). 3441–3450. 50 indexed citations

16.

Okemoto, Kazuo, Kazue Kasai, Amy Haseley, et al.. (2013). DNA Demethylating Agents Synergize with Oncolytic HSV1 against Malignant Gliomas. Clinical Cancer Research. 19(21). 5952–5959. 23 indexed citations

17.

Bid, Hemant K., Doris A. Phelps, Linlin Xiao, et al.. (2013). Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma. Clinical Cancer Research. 19(24). 6716–6729. 49 indexed citations

18.

Bid, Hemant K., Cheryl A. London, Haihong Zhong, et al.. (2013). Dual Targeting of the Type 1 Insulin-like Growth Factor Receptor and Its Ligands as an Effective Antiangiogenic Strategy. Clinical Cancer Research. 19(11). 2984–2994. 18 indexed citations

19.

Mao, Yicheng, Georgia Triantafillou, Erin Hertlein, et al.. (2012). Milatuzumab-Conjugated Liposomes as Targeted Dexamethasone Carriers for Therapeutic Delivery in CD74+ B-cell Malignancies. Clinical Cancer Research. 19(2). 347–356. 26 indexed citations

20.

Mo, Xiaokui. (2002). Cooperative action of the nit2 and nit4 transcription factors upon gene expression and the identification of cys-13 gene encoding sulfate permease-I in neurospora crassa /. OhioLink ETD Center (Ohio Library and Information Network). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact